Replies to post #429446 on Amarin Corp Plc (AMRN)

[rosemountbomber]

Unfortunately I am not as confident. What I can’t understand is how someone who should know his way around the stock market could possible authorize or pursue a RS, if indeed that is what actually happens. A RS split is not negative only when a company has positive and growing earnings. Otherwise the loss per share gets magnified and the market drives the stock price back from whence it came prior to RS.

But I appreciate your post as it gives me a glimmer of hope that the nonsense of a RS is not undertaken.

[xblkbk]

BbI,

Don’t know if this has already been posted, but GoodRx is saying switch from generic V to brand V for less money!!!

Per their “exclusive manufacturer discount”:

30 day, branded V, retailing for $406.65, is $98.40 with GoodRx

90 day, retailing for $1216, is $295.20 with GoodRx

I know management had talked in the past about the problem that an USA authorized generic’s pricing would disadvantage reimbursement negotiations in the EU. So maybe this “exclusive discount” is a backdoor for the near term??

My script is up for renewal in a few days. Since I’m stuck on Obamacare, where V isn’t covered, I’ve been paying $680 for a 90 day supply with the current Amarin discount. Will use the GoodRx codes and see if they work!!!